European Companies Search Engine
EU funding (€8,603,990): 815568 - Shigetecvax - Early Clinical Development of a Live, Attenuated Combination Vaccine Against Shigella and Etec Diarrhoea Fts1 Sept 2019 Financial Transparency System
Overview
Text
Project
| Subject of Grant or Contract | 815568 - SHIGETECVAX - EARLY CLINICAL DEVELOPMENT OF A LIVE, ATTENUATED COMBINATION VACCINE AGAINST SHIGELLA AND ETEC DIARRHOEA |
| Responsible Department | RTD - Directorate-General for Research and Innovation |
| Programme Name | 1.1.31 - Horizon 2020 |
| Type of Contract* | Action Grant |
| Reference of the Legal Commitment (LC) | JAG.346827 |
| Management Type | Direct management |
| Geographical Zone | - |
| Budget | BGUE |
| Action Location | - |
| Commitment Total Amount (EUR) (A+B) | 8,603,990.00 |
| Project end Date | 31/08/2024 |
| Commitment Contracted Amount (EUR) (A) | 8,603,990.00 |
| Budget Line Name | Improving lifelong health and well-being |
| Funding Type | Grant |
| Additional/Reduced Amount (EUR) (B) | 0.00 |
| Year | 2019 |
| Source of (Estimated) Detailed Amount | An estimated repartition for each beneficiary was available in our central accounting system "ABAC". The actual share may evolve over the lifespan of a project. |
| Reference (Budget) | JAG.346827.1 |
| Commitment Consumed Amount (EUR) | 7,743,591.00 |
| Budget Line Number | 08 02 03 01 |
| Project Start Date | 01/09/2019 |
| Expense Type | Operational |
Beneficiaries
-
Coordinator Yes Address VOSSSTRASSE 2 GEB 4040 Beneficiary’s Contracted Amount (EUR) 359,758.63 Beneficiary’s Estimated Contracted Amount (EUR) 359,758.63 Postal Code 69115 Beneficiary Country Germany Beneficiary’s Estimated Consumed Amount (EUR) 323,782.77 VAT Number of Beneficiary DE815127939 Beneficiary Group Code LE05 Not-for-Profit Organisation (Nfpo) Yes Beneficiary Type Private Companies Name of Beneficiary EUROPEAN VACCINE INITIATIVE EWIV NUTS2 Karlsruhe City HEIDELBERG Non-Governmental Organisation (NGO) Yes -
Coordinator No Address KARL-FARKAS-GASSE 22 Beneficiary’s Contracted Amount (EUR) 5,024,394.56 Beneficiary’s Estimated Contracted Amount (EUR) 5,024,394.56 Postal Code 1030 Beneficiary Country Austria Beneficiary’s Estimated Consumed Amount (EUR) 4,521,955.11 VAT Number of Beneficiary ATU67236145 Beneficiary Group Code LE05 Not-for-Profit Organisation (Nfpo) No Beneficiary Type Private Companies Name of Beneficiary EVELIQURE BIOTECHNOLOGIES GMBH NUTS2 Wien City WIEN Non-Governmental Organisation (NGO) No -
Coordinator No Address VASAPARKEN Beneficiary’s Contracted Amount (EUR) 749,846.33 Beneficiary’s Estimated Contracted Amount (EUR) 749,846.33 Postal Code 405 30 Beneficiary Country Sweden Beneficiary’s Estimated Consumed Amount (EUR) 674,861.69 VAT Number of Beneficiary SE202100315301 Beneficiary Group Code LE04 Not-for-Profit Organisation (Nfpo) No Beneficiary Type Public Bodies Name of Beneficiary GOTEBORGS UNIVERSITET* NUTS2 Vastsverige City GOTEBORG Non-Governmental Organisation (NGO) No -
Coordinator No Address SHAHEED TAJUDDIN AHMED SHARANI 68 Beneficiary’s Contracted Amount (EUR) 1,924,712.55 Beneficiary’s Estimated Contracted Amount (EUR) 1,924,712.55 Postal Code 1212 Beneficiary Country Bangladesh Beneficiary’s Estimated Consumed Amount (EUR) 1,732,241.29 VAT Number of Beneficiary - Beneficiary Group Code LE21 Not-for-Profit Organisation (Nfpo) No Beneficiary Type International Organisations Name of Beneficiary INTERNATIONAL CENTRE FOR DIARRHOEALDISEASE RESEARCH BANGLADESH*ICDDRB NUTS2 - City DHAKA Non-Governmental Organisation (NGO) No -
Coordinator No Address 2201 WESTLAKE AVENUE, SUITE 200 Beneficiary’s Contracted Amount (EUR) 545,277.86 Beneficiary’s Estimated Contracted Amount (EUR) 545,277.86 Postal Code 98121 2767 Beneficiary Country United States Beneficiary’s Estimated Consumed Amount (EUR) 490,750.08 VAT Number of Beneficiary - Beneficiary Group Code LE05 Not-for-Profit Organisation (Nfpo) Yes Beneficiary Type Private Companies Name of Beneficiary PATH NUTS2 - City SEATTLE Non-Governmental Organisation (NGO) No
The filing refers to a past date, and does not necessarily reflect the current state.
The visualizations for "EUROPEAN VACCINE INITIATIVE EWIV - EU funding (€8,603,990): 815568 - Shigetecvax - Early Clinical Development of a Live, Attenuated Combination Vaccine Against Shigella and Etec Diarrhoea"
are provided by
North Data
and may be reused under the terms of the
Creative Commons CC-BY license.
